HOME | DEUTSCH | CONTACT | SITEMAP | IMPRINT
ABOUT | NEWS | PRODUCTS | TECHNOLOGY | INVESTOR RELATIONS | CAREER | PATIENTS
STOCK INFORMATION
REPORTS
COVERAGE
ANNUAL GENERAL MEETING
CORPORATE GOVERNANCE
DIRECTORS' DEALINGS
VOTING RIGHTS ANNOUNCEMENTS
Interim Report 3rd Quarter 2011
Half-year Report 2011
Interim Report 1st Quarter 2011
Annual Report 2010
Prospectus 2011 (German version only)
Interim Report 3rd Quarter 2010
Half-year Report 2010
Interim Report 1st Quarter 2010
Annual Report 2009
Interim Report 3rd Quarter 2009
Half-year Report 2009
Interim Report 1st Quarter 2009
Annual Report 2008
Interim Report 3rd Quarter 2008
Half-year Report 2008
Interim Report 1st Quarter 2008
Annual Report 2007
Interim Report 3rd Quarter 2007
Half-year Report 2007
Interim Report 1st Quarter 2007
Annual Report 2006
Interim Report 3rd Quarter 2006
Half-year Report 2006
Interim Report 1st Quarter 2006
Annual Report 2005
Company report for ordinary shares in the name of the bearer. March 29, 2006 download
For print versions please contact investor@mologen.com
You may need to install the Adobe Reader to open the files.
Mr. Joerg Petrass
Dr. Matthias Schroff
Ms. Arlett Killat
MOLOGEN attains the goals of the renal cancer study with MGN1601 ahead of schedule
the press release
MOLOGEN AG appoints Dr. Stefan M. Manth to the scientific advisory board
To receive our press releases please
click here
TOP OF PAGE | HOME | IMPRINT | DISCLAIMER
REPORTS
ANNOUNCEMENTS REPORTS
You
may need to install the Adobe Reader to open the files.
